The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

Clay W. Walker, MPAS, PA-C, is an assistant professor of family medicine at the Mayo Clinic in Phoenix, Arizona. He has over 8 years of experience in primary care, internal medicine, and ...

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Insurance companies pledged to reduce wait times for prior authorization approvals, with support from Dr Mehmet Oz.

Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.